Haematology Drugs

148 drugs

Quick-reference dosing for 148 haematology medicines, aligned to current UK formularies. Each entry lists adult, paediatric and (where relevant) neonatal doses, renal and hepatic adjustments, contraindications, key interactions, monitoring and clinical pearls — with the source reference. Always confirm doses against current prescribing references before prescribing.

Acalabrutinib

BTK Inhibitor — CLL / MCL
Acenocoumarol

Vitamin K antagonist
Anagrelide

Cytoreductive — Essential Thrombocythaemia
Andexanet Alfa

Factor Xa Inhibitor Reversal
Andexanet Alfa

Factor Xa Reversal Agent
Anti-D (Rh₀) Immunoglobulin

Immunoglobulin (Rh Prophylaxis)
Apixaban

Direct Oral Anticoagulant (Factor Xa Inhibitor)
Argatroban

Direct Thrombin Inhibitor — HIT
Argatroban Monohydrate

Direct Thrombin Inhibitor (Parenterally Administered Anticoagulant)
Asciminib

BCR-ABL1 STAMP Inhibitor (ABL Myristoyl Pocket Binder)
Avatrombopag

Thrombopoietin Receptor Agonist (TPO-RA)
Azacitidine

Hypomethylating Agent — MDS / AML
Belumosudil

ROCK2 inhibitor
Bemiparin sodium

Low molecular weight heparin (LMWH)
Bortezomib

Proteasome Inhibitor — Myeloma
Caplacizumab

Anti-vWF Nanobody — Acquired TTP
Caplacizumab

Anti-vWF nanobody (TTP)
Cladribine

Purine analogue / immunosuppressant
Clodronate disodium

Bisphosphonate
Crizanlizumab

P-selectin Inhibitor — Sickle Cell Disease
Crovalimab

Anti-C5 monoclonal antibody
Cyanocobalamin

Vitamin B12 supplement
Dabigatran etexilate

Direct thrombin (factor IIa) inhibitor (DOAC)
Dabigatran Etexilate

Direct Oral Anticoagulant (Direct Thrombin Inhibitor)
Dalteparin sodium

Low molecular weight heparin (LMWH)
Danaparoid sodium

Heparinoid (factor Xa inhibitor)
Danicopan

Factor D inhibitor (oral complement inhibitor, adjunctive)
Daratumumab

Anti-CD38 Monoclonal Antibody — Myeloma
Daratumumab

Anti-CD38 monoclonal antibody (specialist)
Darbepoetin alfa

Erythropoiesis-stimulating agent (ESA)
Dasatinib

Tyrosine Kinase Inhibitor — CML / Ph+ ALL
Deferasirox

Iron Chelation
Deferasirox

Oral iron chelator
Deferiprone

Iron Chelation — Oral
Deferiprone

Oral iron chelator
Desferrioxamine mesilate

Iron chelator (parenteral)
Desferrioxamine mesilate

Iron chelator (parenteral)
Desferrioxamine Mesilate (Deferoxamine)

Antidote / Chelating Agent
Desmopressin (DDAVP)

Vasopressin analogue / Haemostatic
Dried prothrombin complex

4-factor prothrombin complex concentrate (PCC)
Eculizumab

C5 complement inhibitor (IV monoclonal)
Elranatamab

BCMA×CD3 Bispecific Antibody
Elranatamab

BCMA × CD3 bispecific T-cell engager (specialist)
Eltrombopag

Thrombopoietin Receptor Agonist (TPO-RA)
Emicizumab

Bispecific antibody mimicking factor VIIIa (FIX-FX bridging)
Enasidenib

IDH2 Inhibitor
Enoxaparin

Low Molecular Weight Heparin (LMWH)
Enoxaparin sodium

Low molecular weight heparin (LMWH)
Epoetin Alfa/Beta/Zeta (ESA)

Erythropoiesis-Stimulating Agent
Factor IX (Specialist drug)

Recombinant clotting factor IX
Factor IX Concentrate

Coagulation Factor Replacement — Haemophilia B
Factor VIIa (recombinant)

Recombinant activated factor VII
Factor VIII (Specialist drug)

Recombinant clotting factor VIII
Factor VIII Concentrate

Clotting Factor Concentrate
Factor VIII inhibitor bypassing fraction (Specialist drug)

Activated prothrombin complex concentrate
Factor XIII (Specialist drug)

Plasma-derived factor XIII concentrate
Factor XIII A-subunit (Specialist drug)

Recombinant factor XIII A-subunit
Ferric carboxymaltose

IV iron
Ferric Carboxymaltose

IV Iron — Anaemia
Ferric derisomaltose

IV iron
Ferric maltol

Oral ferric iron
Ferrous fumarate

Oral ferrous iron
Ferrous gluconate

Oral ferrous iron
Ferrous sulfate

Oral ferrous iron
Ferrous sulfate with ascorbic acid

Oral iron + vitamin C
Ferrous sulfate with folic acid

Iron + folate supplement
Ferrous Sulphate

Iron Supplement (Oral)
Fibrinogen (Specialist drug)

Plasma-derived fibrinogen concentrate
Fibrinogen Concentrate

Coagulation Factor Replacement — Hypofibrinogenaemia
Filgrastim (G-CSF)

Granulocyte Colony-Stimulating Factor
Folic acid

Vitamin B9
Folic Acid

Vitamin B group (folate)
Folinic Acid (Calcium Folinate / Leucovorin)

Antidote / Chemotherapy Support
Folinic acid (calcium folinate)

Reduced folate
Fondaparinux sodium

Synthetic factor Xa inhibitor
Fondaparinux Sodium

Selective Factor Xa Inhibitor (Synthetic Pentasaccharide)
Fostamatinib

SYK inhibitor
Fresh frozen plasma (FFP)

Blood component
Gemtuzumab Ozogamicin

Antibody-Drug Conjugate — AML
Gilteritinib

FLT3 Inhibitor
Givosiran

siRNA targeting ALAS1
Haem arginate

Heme replacement
Heparin (unfractionated)

Anticoagulant
Hydroxocobalamin

Vitamin B12 — Megaloblastic Anaemia
Hydroxycarbamide (Hydroxyurea)

Cytoreductive agent / Sickle cell disease / CML
Hydroxycarbamide (Hydroxyurea)

Cytotoxic / Disease-Modifying Agent
Ibrutinib

Bruton's Tyrosine Kinase (BTK) Inhibitor
Idarucizumab

Anticoagulant Reversal — Dabigatran
Idelalisib

PI3Kδ Inhibitor — CLL / Follicular Lymphoma
Imatinib

Tyrosine kinase inhibitor (BCR-ABL)
Inotersen

Antisense oligonucleotide (TTR)
Iptacopan

Complement factor B inhibitor
Iron dextran

IV iron
Iron sucrose

IV iron
Iron Sucrose

IV Iron — Anaemia
Ivosidenib

IDH1 Inhibitor
Lenalidomide

Immunomodulatory Drug (IMiD)
Lenograstim

Recombinant G-CSF
Levofolinic acid (calcium levofolinate)

Reduced folate (active enantiomer of folinic acid)
Lipegfilgrastim

Long-acting recombinant G-CSF
Luspatercept

Erythroid Maturation Agent (TGF-β Ligand Trap)
Lusutrombopag

Thrombopoietin receptor agonist
Marstacimab

Anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody
Menadiol sodium phosphate

Water-soluble vitamin K analogue
Mesna

Uroprotectant
Midostaurin

FLT3 / PKC Inhibitor — AML / Mastocytosis
Mosunetuzumab

CD20×CD3 Bispecific T-Cell Engager
Nilotinib

Tyrosine Kinase Inhibitor — CML
Normal immunoglobulin (IVIG / SCIG)

Pooled human immunoglobulin
Obinutuzumab

Anti-CD20 Monoclonal Antibody — CLL / Follicular Lymphoma
Oxymetholone

Anabolic steroid
Parenteral nutrition supplements

Parenteral nutrition
Patisiran

siRNA targeting transthyretin (TTR)
Pegcetacoplan

C3 complement inhibitor (pegylated peptide)
Pegfilgrastim

Pegylated G-CSF
Phenindione

Indanedione anticoagulant (vitamin K antagonist)
Phytomenadione (Vitamin K1)

Vitamin K (clotting factor cofactor)
Phytomenadione (Vitamin K1)

Vitamin K (Coagulation Factor Synthesis)
Plerixafor

CXCR4 antagonist (HSC mobiliser)
Polatuzumab Vedotin

Antibody-Drug Conjugate (CD79b)
Protamine Sulphate

Heparin Antidote
Protein C (Specialist drug)

Recombinant/plasma-derived protein C concentrate
Pyridoxine hydrochloride

Vitamin B6
Ravulizumab

Long-acting C5 complement inhibitor
Recombinant Factor VIIa

Bypass Agent — Haemophilia with Inhibitors
Rituximab (Haematology)

Anti-CD20 Monoclonal Antibody
Rivaroxaban

Direct Oral Anticoagulant (Factor Xa Inhibitor)
Romiplostim

Thrombopoietin Receptor Agonist (Peptibody)
Ropeginterferon alfa-2b (Specialist drug)

Pegylated long-acting interferon alfa-2b
Ruxolitinib

JAK1/2 Inhibitor
Selinexor

XPO1 (Exportin-1) Inhibitor
Sodium feredetate

Oral iron (sodium iron edetate)
Tafasitamab

CD19-Directed Monoclonal Antibody (Fc-Enhanced)
Teclistamab

BCMA×CD3 Bispecific Antibody
Thalidomide

Immunomodulatory Drug (IMiD) — Myeloma
Thiamine

Vitamin B1
Tinzaparin sodium

Low molecular weight heparin
Tranexamic Acid

Antifibrinolytic
Unfractionated Heparin (UFH)

Anticoagulant (parenteral)
Velaglucerase alfa

Recombinant glucocerebrosidase
Venetoclax

BCL-2 Inhibitor
Von Willebrand factor (Specialist drug)

Plasma-derived or recombinant vWF concentrate
Voxelotor

Haemoglobin S Polymerisation Inhibitor — Sickle Cell Disease
Vutrisiran

siRNA targeting transthyretin (TTR)
Warfarin

Oral anticoagulant (Vitamin K antagonist)
Warfarin sodium

Vitamin K antagonist (anticoagulant)
Zanubrutinib

BTK Inhibitor
Zanubrutinib

BTK inhibitor (specialist)